This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Andree Rothermel, PhD
Authorized Officer and Director Biomarker Development at TRON


Andrée Rothermel has more than 10 years of experience in the development and validation of high-throughput screening technologies for drug and biomarker discovery and scientific project management. He holds a PhD in Biology from the Technische Universität Darmstadt, Germany. In 2008, he qualified as a university lecturer at the Department of Biosciences, Pharmacy and Psychology at Leipzig University. In 2011, he joined the research institute TRON in Mainz as its head of the Biomarker Development Center, where he has also been an authorized officer since 2017. In addition, since 2011 he has led team at BioNTech Diagnostics Mainz, which develops technology platforms for the identification and validation of serological markers. Since 2016 he is also managing director of the Cluster for Individualized Immune Intervention (Ci3) based in Mainz.

Agenda Sessions

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #1: FINDING THE RIGHT ANTIBODY - To prepare for this discussion/Q&A, attendees should view the presentations from Session #1 in the Watch On-Demand Sessions Tab prior to this session

  • Profiling Disease-related Autoantibodies by NGS-based Peptidome-phage-display Screening

    On Demand